Experimental Ebola vaccine in DRC as virus spreads

Experimental Ebola vaccine in DRC as virus spreads
An experimental Ebola treatment is being used to combat the latest flare-up of the virus in the Democratic Republic of the Congo. But the vaccine is only being used in the eastern part of the country which is rife with armed conflict.
Its the first time the antibody – known as mAb114 – has been deployed against an Ebola outbreak. Forty-two people are believed to have died in Congo’s tenth Ebola outbreak since it was discovered in the 1970s

Ebola, which causes fever, vomiting, and diarrhea, finds a natural home in Congo’s forests. Between 2013 and 2016. More than 11,300 people were killed by the virus in West Africa.

Read on EuroNews


Author: HEDGE

Hedge Accordingly was founded ahead of the global financial crisis in January of 2008, with the goal of providing our readers our unique take on The Latest News on Wall Street, Stocks, #Politics and Business news. Hedge Accordingly produces both original, and aggregated #Wallst news content from top publishers around the world. We curate aggregated content covering the latest news on politics, stocks, wall street, and the tech industry. We also provide free stock charting, quotes and a bitcoin, forex and currency exchange. Learn More About HEDGEaccordingly.com